Serious Untoward Incident - Heart of England NHS Foundation Trust
... injury) on premises where health care is provided, or whilst in receipt of healthcare Any event where the actions of health service staff are likely to cause significant public concern Any event that might seriously impact upon the delivery of services and / or which is likely to produce significant ...
... injury) on premises where health care is provided, or whilst in receipt of healthcare Any event where the actions of health service staff are likely to cause significant public concern Any event that might seriously impact upon the delivery of services and / or which is likely to produce significant ...
implications for research - World Health Organization
... Unsafe medical care is a major source of morbidity and mortality throughout the world. In order to understand the scope of the issues facing policy-makers and researchers involved in improving the safety of health care, the World Health Organization (WHO) World Alliance for Patient Safety convened a ...
... Unsafe medical care is a major source of morbidity and mortality throughout the world. In order to understand the scope of the issues facing policy-makers and researchers involved in improving the safety of health care, the World Health Organization (WHO) World Alliance for Patient Safety convened a ...
2008_09_04-Choi-Analgesia__sedation
... Pain Definition •An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. ...
... Pain Definition •An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. ...
Refractory Ascites
... refractory ascites with TIPS than with largevolume paracenteses, but without a survival benefit. However, TIPS cannot be used in patients with advanced, decompensated cirrhosis (eg, Child's class C), because shunting portal blood away from the liver often precipitates liver failure in this group of ...
... refractory ascites with TIPS than with largevolume paracenteses, but without a survival benefit. However, TIPS cannot be used in patients with advanced, decompensated cirrhosis (eg, Child's class C), because shunting portal blood away from the liver often precipitates liver failure in this group of ...
Treatment of Tuberculosis Disease
... Definitions of abbreviations: DOT = directly observed therapy; EMB = ethambutol; INH = isoniazid; HIV = human immunodeficiency virus; PZA = pyrazinamide; RIF = rifampin; RPT = rifapentine. * Definitions of evidence ratings: A = preferred; B = acceptable alternative; C = offer when A and B cannot be ...
... Definitions of abbreviations: DOT = directly observed therapy; EMB = ethambutol; INH = isoniazid; HIV = human immunodeficiency virus; PZA = pyrazinamide; RIF = rifampin; RPT = rifapentine. * Definitions of evidence ratings: A = preferred; B = acceptable alternative; C = offer when A and B cannot be ...
Lung Cancer Clinical Guidelines
... rates, 1999–2003, Thames Cancer Registry). Mortality rates are almost as high, at 47.9 per 100,000 for men and 23.4 per 100,000 for women (average standardised mortality rates, 1999–2003, Thames Cancer Registry). Survival from lung cancer is poor, with less than 10% of patients surviving more than 5 ...
... rates, 1999–2003, Thames Cancer Registry). Mortality rates are almost as high, at 47.9 per 100,000 for men and 23.4 per 100,000 for women (average standardised mortality rates, 1999–2003, Thames Cancer Registry). Survival from lung cancer is poor, with less than 10% of patients surviving more than 5 ...
Product Monograph May 5, 2016
... During hemodialysis, patients treated with EPREX® may require increased anticoagulation with heparin to prevent clotting of the artificial kidney. Clotting of the vascular access (A-V fistula) has occurred at an annualized rate of about 0.25 events per patient-year on EPREX® therapy. Overall, for pa ...
... During hemodialysis, patients treated with EPREX® may require increased anticoagulation with heparin to prevent clotting of the artificial kidney. Clotting of the vascular access (A-V fistula) has occurred at an annualized rate of about 0.25 events per patient-year on EPREX® therapy. Overall, for pa ...
DEMEROL (meperidine hydrochloride
... DEMEROL is indicated for the relief of acute episodes of moderate to severe pain. Geriatrics (> 65 years of age) In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or ...
... DEMEROL is indicated for the relief of acute episodes of moderate to severe pain. Geriatrics (> 65 years of age) In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or ...
PDF - Circulation: Heart Failure
... Background—There are limited data on the prevalence, pathophysiology, and management implications of pulmonary hypertension in patients with obstructive hypertrophic cardiomyopathy and advanced heart failure. Methods and Results—To assess the clinical significance of measured cardiopulmonary hemodyn ...
... Background—There are limited data on the prevalence, pathophysiology, and management implications of pulmonary hypertension in patients with obstructive hypertrophic cardiomyopathy and advanced heart failure. Methods and Results—To assess the clinical significance of measured cardiopulmonary hemodyn ...
Full Prescribing Information including BOXED WARNING
... impossible to rely upon prevalence estimates to predict, at the inception of antipsychotic treatment, which patients are likely to develop the syndrome. Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown. Both the risk of developing tardive dyskinesi ...
... impossible to rely upon prevalence estimates to predict, at the inception of antipsychotic treatment, which patients are likely to develop the syndrome. Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown. Both the risk of developing tardive dyskinesi ...
New Run Sheet Training Presentation
... • Medical Control: Receiving medical control or physician who gave directives or orders – If no orders or directives were given then refer to departmental guidelines • Allergies: List pertinent medication or other allergies • Comm: Communication type when calling Medical Control ...
... • Medical Control: Receiving medical control or physician who gave directives or orders – If no orders or directives were given then refer to departmental guidelines • Allergies: List pertinent medication or other allergies • Comm: Communication type when calling Medical Control ...
Personalized Oncology Through High
... Moshe Talpaz, MD, Professor, Department of Internal Medicine, Hematology/Oncology Arul M. Chinnaiyan, MD, PhD, Professor, Department of Pathology Department of Internal Medicine, Hematology and Oncology David Smith, MD, Professor, Department of Internal Medicine Dale Bixby, MD, PhD, Assistant Profes ...
... Moshe Talpaz, MD, Professor, Department of Internal Medicine, Hematology/Oncology Arul M. Chinnaiyan, MD, PhD, Professor, Department of Pathology Department of Internal Medicine, Hematology and Oncology David Smith, MD, Professor, Department of Internal Medicine Dale Bixby, MD, PhD, Assistant Profes ...
Treatments for Irritable Bowel Syndrome (IBS) PHARMACIST’S LETTER / PRESCRIBER’S LETTER Background
... outcome. About one in four patients treated had symptom improvement. All of the different probiotics, including Lactobacillus, Bifidobacteria, Streptococcus, and combinations, showed a trend toward benefit.1 However, when the degree of improvement in IBS symptoms was considered as reported in fourte ...
... outcome. About one in four patients treated had symptom improvement. All of the different probiotics, including Lactobacillus, Bifidobacteria, Streptococcus, and combinations, showed a trend toward benefit.1 However, when the degree of improvement in IBS symptoms was considered as reported in fourte ...
soliris - Alexion Pharma Canada
... Due to its mechanism of action, the use of Soliris increases the patient's susceptibility to meningococcal infection (Neisseria meningitidis). Meningococcal disease due to any serogroup may occur. To reduce the risk of infection, all patients must be vaccinated against meningococcal infections prior ...
... Due to its mechanism of action, the use of Soliris increases the patient's susceptibility to meningococcal infection (Neisseria meningitidis). Meningococcal disease due to any serogroup may occur. To reduce the risk of infection, all patients must be vaccinated against meningococcal infections prior ...
European Respiratory Society Guidelines on the use of nebulizers
... controlled trial as part of the body of literature of overall good quality and consistency, addressing the specific recommendation (AHCPR levels Ia and Ib). 2) Grade B requires availability of well-conducted clinical studies but no randomized clinical trials on the topic of recommendation (levels II ...
... controlled trial as part of the body of literature of overall good quality and consistency, addressing the specific recommendation (AHCPR levels Ia and Ib). 2) Grade B requires availability of well-conducted clinical studies but no randomized clinical trials on the topic of recommendation (levels II ...
Sleep Disorders Guideline - Group Health Cooperative
... • Cardiovascular issues (hypertension, ischemic heart disease, or cerebrovascular disease) for which OSA would be a concerning additional comorbidity. • Patient is in a mission-critical occupation, such as bus driver, trucker, or pilot. In Epic, use Ref Sleep Disorder (OSA). Patients with snoring an ...
... • Cardiovascular issues (hypertension, ischemic heart disease, or cerebrovascular disease) for which OSA would be a concerning additional comorbidity. • Patient is in a mission-critical occupation, such as bus driver, trucker, or pilot. In Epic, use Ref Sleep Disorder (OSA). Patients with snoring an ...
Medicines policy - Isle of Wight NHS Trust
... Medicines Management’, GMC ‘Good practice in prescribing and managing medicines and devices’ and JRCALC Guidelines provide the standards for all professions to meet in the management of medicines. This policy is to support the implementation of guidance and legislation in the management of medicines ...
... Medicines Management’, GMC ‘Good practice in prescribing and managing medicines and devices’ and JRCALC Guidelines provide the standards for all professions to meet in the management of medicines. This policy is to support the implementation of guidance and legislation in the management of medicines ...
American College of Rheumatology
... ead investigator Joan Merrill, MD, who directs the Clinical Pharmacology Research Program at Oklahoma Medical Research Institute in Oklahoma City, noted that the positive effects could be related to the patients who dropped out if they had more flares. But what’s really important, she said, is tha ...
... ead investigator Joan Merrill, MD, who directs the Clinical Pharmacology Research Program at Oklahoma Medical Research Institute in Oklahoma City, noted that the positive effects could be related to the patients who dropped out if they had more flares. But what’s really important, she said, is tha ...
Natural Supplements 101 Introduction to Herbal Medicines HERB
... elicit desired response. Use enough of the plant or extract to get that response. ...
... elicit desired response. Use enough of the plant or extract to get that response. ...
Drug Therapy
... E. "Keep the tablets locked in a safe place until you need them." Patient teaching regarding sublingual nitroglycerin should include which of the following statements: A. "You can take up to five doses every 3 minutes for chest pain." B. "Chew the tablet for the quickest effect." C. "Keep the tablet ...
... E. "Keep the tablets locked in a safe place until you need them." Patient teaching regarding sublingual nitroglycerin should include which of the following statements: A. "You can take up to five doses every 3 minutes for chest pain." B. "Chew the tablet for the quickest effect." C. "Keep the tablet ...
Disease Management Programs in the Medicaid Population
... practices and with 546 continuously insured patients who exhibited claims markers for coronary artery disease, diabetes, and/or hypertension. During the intervention portion of the study, they asked physicians to improve the following health measurements: blood pressure, body mass index, cholesterol ...
... practices and with 546 continuously insured patients who exhibited claims markers for coronary artery disease, diabetes, and/or hypertension. During the intervention portion of the study, they asked physicians to improve the following health measurements: blood pressure, body mass index, cholesterol ...
$doc.title
... date. Through direct patient contact, interns grow into the role of a chiropractic physician. This period is divided into three trimesters of outpatient operations. The outpatient clinics are clinical settings under the authority of the Dean of Clinics and directly overseen by the Chair of Clinical ...
... date. Through direct patient contact, interns grow into the role of a chiropractic physician. This period is divided into three trimesters of outpatient operations. The outpatient clinics are clinical settings under the authority of the Dean of Clinics and directly overseen by the Chair of Clinical ...
alternative health practices in addiction treatment
... The goal of this chapter is to provide basic information for (1) researchers and students unfamiliar with CAM in the treatment of substance abuse, (2) addiction clinicians not necessarily interested in using alternative therapies themselves, so they will be equiped to answer questions from patients ...
... The goal of this chapter is to provide basic information for (1) researchers and students unfamiliar with CAM in the treatment of substance abuse, (2) addiction clinicians not necessarily interested in using alternative therapies themselves, so they will be equiped to answer questions from patients ...
FEB 06 2004 Memorandum
... the referencedStudieSare qualitativelyor quantitativelysimilar to your ingredient or how these studiesare relevantto evaluatingthe safeuseof your ingredientunderthe recommended conditionsof use. For the reasonsdiscussedabove,the informationin your submissiondoesnot provide an adequatebasisto conclud ...
... the referencedStudieSare qualitativelyor quantitativelysimilar to your ingredient or how these studiesare relevantto evaluatingthe safeuseof your ingredientunderthe recommended conditionsof use. For the reasonsdiscussedabove,the informationin your submissiondoesnot provide an adequatebasisto conclud ...